RT Journal Article
SR Electronic
T1 Automated vision screening of children using a mobile graphic device
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.29.21255800
DO 10.1101/2021.04.29.21255800
A1 Kane, Steven A.
A1 Gaspich, Mark
A1 Kane, Julia
A1 Weitzman, Sarah
A1 Hofeldt, Albert
YR 2021
UL http://medrxiv.org/content/early/2021/05/05/2021.04.29.21255800.abstract
AB Background/Objective Can measures of interocular brightness disparity, acuity, and colour vision identify children with amblyopia?Subjects/Methods 208 subjects from 3 to 14 years were recruited for a prospective, observational protocol to measure interocular brightness disparity, acuities with and without a pinhole, and colour vision using an iPad. Interocular brightness disparity was assessed as the subject looked through a system of polarizing filters and chose the brighter of two spaceships. The differential brightness of image pairs was varied according to a staircase algorithm until equal brightness was perceived. Acuities were tested with tumbling Es. Colour vision was tested with AO-HRR colour plates. 2 subjects (1%) were later confirmed to have unilateral amblyopia.Results Binocular brightness balance on the iPad detected both amblyopes and excluded all 202 non-amblyopes, in this study with sensitivity and specificity of 100%. By using 20/30 as cutoff for normal acuity, 1 of the 2 amblyopes was detected and all non-amblyopes were excluded by visual acuity testing with pinhole. The mean difference between iPad and E-Chart visual acuities with pinhole was 0.02 logMAR with limits of agreement from -0.08 to +0.11 logMAR. Colour vision testing with iPad and printed plates gave identical results. Testing times were brief and exit pleasure poll responses were positive.Conclusions Interocular brightness disparity, acuity, and colour vision can be measured in children as young as 3 years playing a fun game on a mobile graphic device. Interocular brightness disparity may be a sensitive and specific method to detect unilateral amblyopia.Competing Interest StatementDr Kane, Mark Gaspich, Julia Kane and Sarah Weitzman declare no conflict of interest. Dr. Hofeldt holds a patent relating to the content of a manuscript. This study was unfunded.Funding StatementThis study was unfunded.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study utilized a prospective, observational protocol that followed all the tenets of the Declaration of Helsinki and was approved by the Columbia University Institutional Review Board (protocol AAAC0020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesn/a